68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.

Valentina Ambrosini, Davide Campana, Vincenzo Allegri, Giuseppe Opocher, Stefano Fanti

Research output: Contribution to journalArticle

Abstract

A case of Von-Hippel Lindau (VHL) disease has been studied using 68Ga-DOTA-NOC PET/CT. PET/CT demonstrated the presence of somatostatin receptors within 2 focal areas in the cerebellum corresponding to the lesions detected by MRI. Considering the heterogeneous lesions localizations in VHL disease, PET/CT may be a useful imaging modality for diagnosing lesions of central nervous system and neuroendocrine lesions and for direct demonstration of somatostatin receptors for targeted treatment.

Original languageEnglish
Pages (from-to)64-65
Number of pages2
JournalClinical Nuclear Medicine
Volume36
Issue number1
Publication statusPublished - Jan 2011

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of '68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.'. Together they form a unique fingerprint.

  • Cite this